S
Physician ReviewerMBBS, MD, DM (Gastroenterology)

Dr. S.K. Sarin, MBBS, MD, DM (Gastro), FNA

Senior Professor & Director, Institute of Liver & Biliary Sciences (ILBS), New Delhi

License VerifiedActive & In Good Standing

ID: DMC-07612

Delhi Medical Council (DMC) & National Academy of Medical Sciences (NAMS)

Professional Background & Bio

Dr. Shiv Kumar Sarin is a globally acclaimed hepatologist, Senior Professor, and Director of the Institute of Liver and Biliary Sciences (ILBS), New Delhi. Recipient of the Padma Bhushan award and former President of the Asian Pacific Association for the Study of the Liver (APASL), he is a world leader in fatty liver disease, liver cirrhosis, and metabolic gastrointestinal disorders.

Medical Specialization

Hepatology, Gastroenterology, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Cirrhosis, Gut Health

Clinical Experience

38+ Years Clinical Hepatology & Academic Research

Hospital / Clinical Affiliation

Director & Head, Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), Vasant Kunj, New Delhi

Education & Medical Training
  • DM in Gastroenterology - All India Institute of Medical Sciences (AIIMS), New Delhi
  • MD in General Medicine - SMS Medical College, Jaipur
  • MBBS - SMS Medical College, Jaipur

Academic Thesis & Medical Research

700+ High-Impact Articles (The Lancet, Hepatology, Gastroenterology, NEJM)
Postgraduate Thesis / Dissertation Title:

“Pathogenesis and Hemodynamics of Sinusoidal and Pre-Sinusoidal Portal Hypertension: Gastric Variceal Anatomy and Endoscopic Sclerotherapy Protocols”

Institution: All India Institute of Medical Sciences (AIIMS), New Delhi

Doctorate of Medicine (DM) superspecialty dissertation establishing the globally adopted 'Sarin Classification of Gastric Varices' and prospective randomized clinical trials on endoscopic cyanoacrylate obliteration versus non-selective beta-blockers.

Key Investigative & Clinical Research Domains:
• Acute-on-Chronic Liver Failure (ACLF) Global Definitions & APASL Consensus• Non-Alcoholic Fatty Liver Disease (MASLD / MASH) Biomarkers & Reversal• Portal Hemodynamics, Hepatic Venous Pressure Gradient (HVPG)• Liver Regeneration & Stem Cell Therapy in Cirrhosis

Clinical Areas Reviewed for mediguide4u:

Non-Alcoholic Fatty Liver Disease (MASLD / MASH) Progression & ReversalLiver Enzyme Interpretation (ALT, AST, GGT, Alkaline Phosphatase)Metabolic Syndrome, Insulin Resistance & Visceral AdiposityNutritional Deficiencies (Vitamin B12, Iron, Vitamin D) & Absorption PathwaysGastroesophageal Reflux Disease (GERD) & Gut Microbiome Dysbiosis
Conflict-of-Interest & Editorial Independence Disclosure

Dr. Sarin has zero corporate pharmaceutical ties. Reviews strictly adhere to APASL, AASLD, and EASL clinical guidelines.

Upcoming Publications

More articles by this clinical expert are currently in the editorial review pipeline.